These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13023513)

  • 1. Chloromycetin palmitate; observations on absorption, blood serum levels, and urinary excretion.
    YOW EM; TAYLOR FM; HIRSCH J; FRANKEL RA; CARNES HE
    J Pediatr; 1953 Feb; 42(2):151-6. PubMed ID: 13023513
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels and urinary excretion of chloramphenicol in the presence of isoniazid and salicylate.
    Mattila MJ; Takki S; Heino AE
    Ann Med Exp Biol Fenn; 1969; 47(3):203-8. PubMed ID: 5367516
    [No Abstract]   [Full Text] [Related]  

  • 3. Chloromycetin palmitate; a synthetic ester of chloromycetin.
    GLAZKO AJ; EDGERTON WH; DILL WA; LENZ WR
    Antibiot Chemother (Northfield); 1952 May; 2(5):234-42. PubMed ID: 24541898
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of ethacrynic acid, hydrochlorothiazide and clopamide on the renal excretion of chloramphenicol and its metabolites.
    Schück O; Nádvorníková H; Grafnetterová J
    Int J Clin Pharmacol Biopharm; 1978 May; 16(5):217-9. PubMed ID: 649239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloromycetin palmitate; clinical evaluation in allergic and non-allergic children and adults.
    THOMAS JW; KELLY FR; EDMONDS AM; KENDIG EL
    Va Med Mon (1918); 1952 May; 79(5):272-4. PubMed ID: 14943010
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of chloromycetin palmitate in infants and children: a preliminary report.
    ROSS S; BURKE FG; RICE EC
    Antibiot Chemother (Northfield); 1952 Apr; 2(4):199-207. PubMed ID: 24541827
    [No Abstract]   [Full Text] [Related]  

  • 7. Stool concentrations and absorption of chloramphenicol and its palmitate in babies.
    SPEIRS AL
    Br J Pharmacol Chemother; 1954 Mar; 9(1):59-61. PubMed ID: 13149777
    [No Abstract]   [Full Text] [Related]  

  • 8. The evaluation of chloromycetin palmitate.
    FINN JJ; KANE LW
    Bull New Engl Med Cent; 1951 Dec; 13(6):241. PubMed ID: 14896283
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of chloromycetin palmitate in infants and children.
    ROSS S; BURKE FG; RICE EC
    Clin Proc Child Hosp Dist Columbia; 1951 Aug; 7(9):243-7. PubMed ID: 14870333
    [No Abstract]   [Full Text] [Related]  

  • 10. Chloromycetin palmitate in the treatment of pneumococcal pneumonia.
    FINN JJ; KANE LW; FINN RE
    Bull New Engl Med Cent; 1952; 14(2):61-3. PubMed ID: 14935494
    [No Abstract]   [Full Text] [Related]  

  • 11. Chloromycetin palmitate; its use in pediatrics.
    LARKIN VD
    Proc Soc Exp Biol Med; 1951 Oct; 78(1):191-3. PubMed ID: 14891962
    [No Abstract]   [Full Text] [Related]  

  • 12. Concentration of chloramphenicol in the urine and blood in relation to renal function.
    Lindberg AA; Nilsson LH; Bucht H; Kallings LO
    Br Med J; 1966 Sep; 2(5516):724-8. PubMed ID: 5917389
    [No Abstract]   [Full Text] [Related]  

  • 13. The dosage of chloromycetin palmitate in children.
    MOSSBERG HO
    Acta Paediatr (Stockh); 1954 Mar; 43(2):174-80. PubMed ID: 13158007
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of meningitis with chloromycetin palmitate; results of therapy in twenty-three cases.
    DEANE GE; FURMAN JE; BENTZ AR; WOODWARD TE
    Pediatrics; 1953 Apr; 11(4):368-80. PubMed ID: 13055347
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of blood level and of the methods of elimination of D, L and DL chloramphenicol in laboratory animals].
    FRANCOVA V; HAIS IM
    Cas Lek Cesk; 1955 Jun; 94(26):709-15. PubMed ID: 13250537
    [No Abstract]   [Full Text] [Related]  

  • 16. Chloramphenicol succinate kinetics in infants and young children.
    Sack CM; Koup JR; Opheim KE; Neeley N; Smith AL
    Pediatr Pharmacol (New York); 1982; 2(2):93-103. PubMed ID: 12760401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Special characteristics of absorption and excretion of chloramphenicol in premature and newborn infants.
    Nishimura T; Kotani Y
    Bull Osaka Med Sch; 1970 Oct; 16(2):169-81. PubMed ID: 5511545
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential CSF concentration of chloramphenicol after administration of oral chloramphenicol palmitate.
    Rensimer ER; Pickering LK; Ericsson CD; Kramer WG
    Lancet; 1981 Jan; 1(8212):165. PubMed ID: 6109852
    [No Abstract]   [Full Text] [Related]  

  • 19. Absorption and excretion of two chloramphenicol products in humans after oral administration.
    Bartelloni PJ; Calia FM; Minchew BH; Beisel WR; Ley HL
    Am J Med Sci; 1969 Sep; 258(3):203-8. PubMed ID: 5824862
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of chloramphenicol on the mother and baby. II. Transfer, absorption, excretion and adverse effects of chloramphenicol in the newborn infant].
    Kunii K
    Jpn J Antibiot; 1970 Aug; 23(4):363-78. PubMed ID: 5312787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.